2026 NPPES data Registered Nurse NPI 1124448428 N.P.
Verify on CMS →

BETH DOMBROWSKI, N.P.

Registered Nurse in MANSFIELD, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 378 beneficiaries · Registered Nurse avg: 1K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$1.1K
39 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BETH DOMBROWSKI, N.P. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 3,370 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
3K
Part D claims, 2023
82%
generic prescribing
$1.1K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BETH DOMBROWSKI, N.P.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about BETH DOMBROWSKI, N.P.?

High performer (top quartile)

NPI registry status

Active

Issued 04/24/2014

NPI 1124448428

Primary specialty

Registered Nurse

High-volume

175,652 US NPIs in this specialty

Medicare Part D claims

3,370 237% vs specialty avg

2023 prescription claims

Specialty avg: 1,000

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Registered Nurse compares to other specialties among Massachusetts providers

Massachusetts providers

Registered Nurse share within Massachusetts

1. Registered Nurse42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Registered Nurse share within Massachusetts

Medicare quality performance — MIPS

BETH DOMBROWSKI, N.P.'s 2023 MIPS final score plotted against the Registered Nurse national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Registered Nurse) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Registered Nurse) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BETH DOMBROWSKI, N.P. appears in the CMS NPPES registry as a Registered Nurse provider holding N.P. credentials at 200 COPELAND DR, MANSFIELD, MA, 02048, with a listed phone of (508) 339-4144. NPI 1124448428 was issued on 04/24/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DOMBROWSKI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,370 prescription claims written by this provider, covering 378 Medicare beneficiaries and totaling roughly $429K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 1.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.

Registered Nurse is a high-volume specialty nationwide, with 175,652 enrolled providers across 56 states and an average of 1,000 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

200 COPELAND DR
MANSFIELD, MA 02048

Provider Details

NPI 1124448428
Specialty Registered Nurse
Credentials N.P.
Gender Female
NPI Issued 04/24/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where BETH DOMBROWSKI, N.P. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

STURDY HEALTH INC
MANSFIELD, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BETH DOMBROWSKI, N.P.. Source: openpaymentsdata.cms.gov.

Total received

$1.1K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to BETH DOMBROWSKI, N.P.. To verify BETH DOMBROWSKI, N.P.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

BETH DOMBROWSKI, N.P. — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 3,370 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,370
Total Claims
$429K
Total Drug Cost
378
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,635
Total Day Supply
189,657
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$369K
Generic Drug Cost
$57K
Opioid Claims
36 (1.1% rate)
Antibiotic Claims
153

Patient Demographics

Average Patient Age
69.6 years
Avg HCC Risk Score
1.17
Gender Split
61% female / 39% male
Age Distribution
<65: 72, 65-74: 177, 75-84: 103, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BETH DOMBROWSKI, N.P. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Lisinopril
174
Atorvastatin Calcium
164
Omeprazole
109
Albuterol Sulfate Hfa
Albuterol Sulfate
103
Metformin Hcl
100
Amlodipine Besylate
98
Levothyroxine Sodium
95
Rosuvastatin Calcium
94
Gabapentin
81
Prednisone
66

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Registered Nurse Overview

How BETH DOMBROWSKI, N.P. fits within the Registered Nurse landscape nationally.

175,652
Registered Nurse Providers in US
56
States with Registered Nurse
1,000
Avg Claims per Provider

BETH DOMBROWSKI, N.P.'s 3,370 claims are above the specialty average of 1,000.

Nearby Registered Nurse Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as DOMBROWSKI.

Compare Registered Nurse nationally: see state-by-state distribution →

Frequently Asked Questions

What is BETH DOMBROWSKI, N.P.'s specialty?
BETH DOMBROWSKI, N.P. specializes in Registered Nurse and practices in MANSFIELD, Massachusetts. Credentials: N.P..
How much does BETH DOMBROWSKI, N.P. prescribe under Medicare Part D?
In 2023, BETH DOMBROWSKI, N.P. wrote 3,370 Medicare Part D claims totaling $429K in drug costs for 378 beneficiaries.
What is BETH DOMBROWSKI, N.P.'s Medicare quality score?
BETH DOMBROWSKI, N.P. has a CMS MIPS Final Score of 100/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BETH DOMBROWSKI, N.P. located?
BETH DOMBROWSKI, N.P. is located at 200 COPELAND DR, MANSFIELD, MA, 02048. Phone: (508) 339-4144.
What is BETH DOMBROWSKI, N.P.'s NPI number?
BETH DOMBROWSKI, N.P.'s National Provider Identifier (NPI) is 1124448428, issued on 04/24/2014.
Does BETH DOMBROWSKI, N.P. prescribe more brand-name or generic drugs?
BETH DOMBROWSKI, N.P.'s prescribing is 18% brand-name and 82% generic drugs by claim count, with $369K in brand drug costs.
Does BETH DOMBROWSKI, N.P. prescribe opioids?
Yes, BETH DOMBROWSKI, N.P. had 36 opioid claims in 2023 with an opioid prescribing rate of 1.1%.
How many Registered Nurse providers are there in the US?
There are 175,652 Registered Nurse providers across 56 states in the US. The average Registered Nurse provider writes 1,000 Medicare Part D claims per year.
What drugs does BETH DOMBROWSKI, N.P. prescribe most often?
Based on 2023 Medicare Part D data, BETH DOMBROWSKI, N.P.'s most frequently prescribed drugs include Lisinopril, Atorvastatin Calcium, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BETH DOMBROWSKI, N.P. accept Medicare?
BETH DOMBROWSKI, N.P. appears in CMS Medicare data with 3,370 Part D claims and 378 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BETH DOMBROWSKI, N.P.'s credentials?
BETH DOMBROWSKI, N.P.'s NPI is 1124448428 with credentials N.P.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology